期刊文献+

血管内皮生长因子、p53与肺癌的关系研究进展

Progress of Relationship Among VEGF、p53 and lung Cancer
下载PDF
导出
摘要 血管内皮生长因子(VEGF)是一种与肿瘤关系最为密切的血管生成因子。VEGF对肺癌组织的生长和扩散有重要影响。p53是一种重要的抑癌基因。已有研究表明,野生型p53可以抑制VEGF的表达,并通过旁观效应抑制肿瘤的生长和转移,而突变型p53则可以上调VEGF的表达,促进血管生成并促进肿瘤的生长和转移,但也有相反的报道。本文就VEGF、p53蛋白与肺癌关系研究的进展简要综述。 Vascular endothelial growth factor(VEGF) is a factor of angiogenesis closely associated with tumor. VEGF has an important effects on growth and metastasis of lung cancer tissues, p53 is an important anti-oncogen. Studies showed that p53 of wild type could inhibit the expression of VEGF as well as inhibit the growth and metastasis of tumors by looking on effects, but mutant p53 could up-regulate the expression of VEGF and promote vascularlzation as well as the growth and metastasis of tumor. At the same time reverse conclusiou was reported. The article is a review about advances in researching the relationship among VEGF, p53 and lung cancer.
出处 《医学综述》 2006年第22期1377-1379,共3页 Medical Recapitulate
关键词 肺肿瘤 血管内皮生长因子 P53 血管生成 Lung cancer Vascular endothelial growth factor p53 Vascularization
  • 相关文献

参考文献20

  • 1Fujiwara T,Nishizaki M,Tanaka N,et al.Recombinant adenovirus expressing wild-type p53 is antiangiogenic-implication for lung cancer gene therapy[J].Gan To Kagaku Ryoho,2000,27(8):1217-1224.
  • 2Koukourakis MI,Giatromanolaki A,O' Byrne KJ,et al.Bcl-2 and cerbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small cell lung cancer[J].Clin Exp Metastas,1999,17 (7):545-554.
  • 3Ono K,Hattori H,Takeshita S,et al.Structural features in heparin that interact with VEGF165 and modulate its biological activity[J].Glycobiology,1999,9(7):705-711.
  • 4Starovasnik MA,Christinger HW,Wiesmann C,et al.Solution structure of the VEGF-binding domain of Flt-1:comparison of its free and bound states[J].J Mol Biol,1999,293(3):531-544.
  • 5Konishi T,Huang CL,Adachi M,et al.The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers[J].Int J Oncol,2000,16(3):501-511.
  • 6O'Byrne KJ,Koukourakis MI,Giatromanolaki A,et al.Vascular endothelial growth factor,Platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer[J].Br J Cancer,2000,82(8):1427-1432.
  • 7Yano T,Tanikawa S,Fujie T,et al.Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer[J].Eur J Cancer,2000,36(5):601-609.
  • 8Barr LF,Campbell SE,Diette GB,et al.C-myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression[J].Cancer Res,2000,60(1):143-149.
  • 9Rowe DH,Huang J,Kayton ML,et al.Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor[J].J Pediatr Surg,2000,35(1):30-32.
  • 10Carter SK.Clinical Strategy for the development of angiogenesis inhibitots[J].Oncologist,2000,5 (Suppl 1):51-54.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部